Detalhe da pesquisa
1.
Potential Clinical Significance of Overall Targeting Accuracy and Motion Management in the Treatment of Tumors That Move With Respiration: Lessons Learnt From a Quarter Century of Stereotactic Body Radiotherapy From Dose Response Models.
Front Oncol
; 10: 591430, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33634020
2.
Whole-pelvis, "mini-pelvis," or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial.
Int J Radiat Oncol Biol Phys
; 66(3): 647-53, 2006 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17011443
3.
Introduction and Clinical Overview of the DVH Risk Map.
Semin Radiat Oncol
; 26(2): 89-96, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27000504
4.
Validity of Current Stereotactic Body Radiation Therapy Dose Constraints for Aorta and Major Vessels.
Semin Radiat Oncol
; 26(2): 135-9, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27000510
5.
Small Bowel Dose Tolerance for Stereotactic Body Radiation Therapy.
Semin Radiat Oncol
; 26(2): 157-64, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27000513
6.
Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31.
Int J Radiat Oncol Biol Phys
; 61(5): 1285-90, 2005 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15817329
7.
The impact of regional nodal radiotherapy (dose/volume) on regional progression and survival in unresectable non-small cell lung cancer: an analysis of RTOG data.
Lung Cancer
; 41(2): 207-14, 2003 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12871784
8.
Low toxicity for lung tumors near the mediastinum treated with stereotactic body radiation therapy.
Pract Radiat Oncol
; 3(2): 130-7, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24674316
9.
Stereotactic body radiotherapy as an alternative to brachytherapy in gynecologic cancer.
Biomed Res Int
; 2013: 898953, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24000329
10.
Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-risk prostate cancer: preliminary toxicity analysis of RTOG 99-02.
Int J Radiat Oncol Biol Phys
; 73(3): 672-8, 2009 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18990504
11.
The importance of protein kinase A in prostate cancer: relationship to patient outcome in Radiation Therapy Oncology Group trial 92-02.
Clin Cancer Res
; 15(17): 5478-84, 2009 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19706804
12.
Prognostic value of p16 in locally advanced prostate cancer: a study based on Radiation Therapy Oncology Group Protocol 9202.
J Clin Oncol
; 25(21): 3082-9, 2007 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-17634487
13.
Race and survival of men treated for prostate cancer on radiation therapy oncology group phase III randomized trials.
J Urol
; 169(1): 245-50, 2003 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-12478146